Art. 35 Directive (EU) 2001/83

In forcesince 21 Mar 2008cited 10×
1.

Any application by the marketing authorization holder to vary a marketing authorization which has been granted in accordance with the provisions of this Chapter shall be submitted to all the Member States which have previously authorized the medicinal product concerned.

The Commission shall, in consultation with the Agency, adopt appropriate arrangements for the examination of variations to the terms of a marketing authorization.

These arrangements shall include a notification system or administration procedures concerning minor variations and define precisely the concept of ‘a minor variation’.

These arrangements shall be adopted by the Commission in the form of an implementing regulation. That measure, designed to amend non-essential elements of this Directive by supplementing it, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 121(2a).

2.

In case of arbitration submitted to the Commission, the procedure laid down in Articles 32, 33 and 34 shall apply by analogy to variations made to marketing authorizations.

  • Directive (EU) 2004/27Lawamends

  • Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination o…Law

    … 67.], και ιδίως το άρθρο 35 παράγραφος 1, τον κανονισμό (ΕΚ) αριθ. 726/2004 του Ευρωπαϊκού Κοινοβουλίου και του Συμβουλίου, της 31ης Μαρτίου …

  • Opinion of Mr Advocate General Bot delivered on 10 July 2008. The Queen, on the application of Synthon BV v Licensing Authority of the DeparDecision

    Directive 2001/83 then includes a Chapter 4, entitled ‘Mutual recognition of authorisations’. This chapter, which encompasses Articles 27 to 39, occupies a central place in these preliminary reference proceedings.

    10 Jul 2008 · 62006CC0452

  • Judgment of the Court of First Instance (Fifth Chamber) of 31 January 2006. Merck Sharp & Dohme Ltd and Others v Commission of the European Decision

    Chapter 4 (‘Mutual recognition of authorisations’) of Title III HUM (‘Placing on the market’) contains the following provisions: ‘Article 27 [corresponding to Article 8 of Directive 75/319, as amended]: In order to facilitate the …

    31 Jan 2006 · 62003TJ0273

  • Directive (EU) 2009/53Lawamends

    В член 39 от Директива 2001/82/ЕО и член 35 от Директива 2001/83/ЕО Комисията се оправомощава да приеме регламент за прилагане по отношение …

  • Order of the Court of First Instance (Fourth Chamber) of 2 June 2004. Pfizer Ltd v Commission of the European Communities.Decision

    Lastly, the first indent of Article 4 of Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the EMEA (OJ 1995 L 35 p. 1), as amended by Council Regulation (EC) No 2743/98 of 14 December 1998 (OJ 1998 L 345, p. 3) …

    2 Jun 2004 · 62003TO0123

  • Directive (EU) 2008/29Lawamends

  • Opinion of Advocate General Kokott delivered on 4 October 2018. Staat der Nederlanden v Warner-Lambert Company LLC.Decision

    Article 35(1) of Directive 2001/83 permits an application to vary an authorisation: ‘Any application by the marketing authorisation holder to vary a marketing authorisation … shall be submitted to all the Member States which have …

    4 Oct 2018 · 62017CC0423

  • Opinion of Advocate General Saugmandsgaard Øe delivered on 1 December 2016. Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota.Decision

    I recall, moreover, that such medicinal products come under Directive 2001/83 and, accordingly, under the rules of free movement based on mutual recognition of marketing authorisations as provided for in Articles 28 to 39 of that …

    1 Dec 2016 · 62015CC0296

  • Judgment of the Court of First Instance (Fifth Chamber) of 31 January 2006. Albert Albrecht GmbH & Co. KG and Others v Commission of the EurDecision

    31 Jan 2006 · 62003TJ0251